| Typicality: | 0.372 |
| Saliency: | 0.491 |
| on age-related macular degeneration | 5 | transitive-object |
| in mouse models of the disease | 5 | location |
| on lipid metabolism | 3 | transitive-object |
| compound → have → beneficial effects | 22 |
| compound → have → beneficial effect | 9 |
| compound → exert → its beneficial effects | 4 |
| negative | neutral | positive |
| 0.020 | 0.343 | 0.637 |
| Raw frequency | 35 |
| Normalized frequency | 0.491 |
| Modifier score | 0.500 |
| Perplexity | 104.486 |